Mönnikes, Hubert <br/><br/>
Possible etiology of improvements in both quality of life and overlapping gastroesophageal reflux disease by proton pump inhibitor treatment in a prospective randomized controlled trial.  [electronic resource] 

 -  BMC gastroenterology  Oct 2013 
 - 145 p.  digital 
<br/><br/> Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1471-230X 
<br/><br/><label>Standard No.: </label>10.1186/1471-230X-13-145  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>2-Pyridinylmethylsulfinylbenzimidazoles--therapeutic use<br/>Adult<br/>Aged<br/>Dyspepsia--complications<br/>Esophagitis, Peptic--drug therapy<br/>Female<br/>Gastroesophageal Reflux--complications<br/>Humans<br/>Irritable Bowel Syndrome--complications<br/>Male<br/>Middle Aged<br/>Pantoprazole<br/>Proton Pump Inhibitors--therapeutic use<br/>Quality of Life<br/>Treatment Outcome